{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:55:59Z","timestamp":1781510159628,"version":"3.54.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001232","name":"Royal Australasian College of Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000940","name":"Arthritis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023360","name":"St Vincent&apos;s Hospital Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.berh.2026.102124","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:09:59Z","timestamp":1772600999000},"page":"102124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent advances in the heart and soul of primary cardiac involvement and cardiovascular disease in systemic sclerosis"],"prefix":"10.1016","volume":"40","author":[{"given":"Laura","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2813-2083","authenticated-orcid":false,"given":"Cosimo","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.berh.2026.102124_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103506","article-title":"Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): recent and advanced data","volume":"23","author":"Thoreau","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.berh.2026.102124_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.semarthrit.2021.03.011","article-title":"Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: a systematic review and meta-analysis of long-term outcomes","volume":"51","author":"Brown","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2026.102124_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard-2024-226430","article-title":"EULAR recommendations for the treatment of systemic sclerosis: 2023 update","volume":"84","author":"Del Galdo","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2026.102124_bib4","article-title":"ERS\/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease","author":"Antoniou","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"38","key":"10.1016\/j.berh.2026.102124_bib5","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.berh.2026.102124_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/23971983211053246","article-title":"Primary systemic sclerosis heart involvement: a systematic literature review and preliminary data-driven, consensus-based WSF\/HFA definition","volume":"7","author":"Bruni","year":"2022","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.berh.2026.102124_bib7","article-title":"Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement","author":"Ross","year":"2025","journal-title":"medRxiv"},{"issue":"3","key":"10.1016\/j.berh.2026.102124_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2021.101668","article-title":"Cardiac involvement in systemic sclerosis: getting to the heart of the matter","volume":"35","author":"Bruni","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102124_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/23971983231163413","article-title":"Consensus on the assessment of systemic sclerosis\u2013associated primary heart involvement: World scleroderma foundation\/heart failure association guidance on screening, diagnosis, and follow-up assessment","volume":"8","author":"Bruni","year":"2023","journal-title":"Journal of Scleroderma and Related Disorders"},{"key":"10.1016\/j.berh.2026.102124_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152739","article-title":"Pathological contributors to organ damage and mortality in systemic sclerosis: a nationwide matched case-control study","volume":"73","author":"Fairley","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2026.102124_bib11","first-page":"656","article-title":"A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma)","volume":"17","author":"Follansbee","year":"1990","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102124_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.berh.2026.102124_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/25.2.158","article-title":"Reversible myocardial perfusion defects during cold challenge in scleroderma","volume":"25","author":"Long","year":"1986","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102124_bib14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/eurjhf\/hfp198","article-title":"Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study","volume":"12","author":"Mizuno","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.berh.2026.102124_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11112165","article-title":"Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: frequency, clinical and Prognostic correlates","volume":"11","author":"Caforio","year":"2021","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.berh.2026.102124_bib16","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jacbts.2024.08.008","article-title":"Macrophages contribute to cardiac fibrosis and diastolic dysfunction in systemic sclerosis","volume":"9","author":"Jones","year":"2024","journal-title":"JACC Basic Transl Sci"},{"issue":"21","key":"10.1016\/j.berh.2026.102124_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cells14211679","article-title":"Exploring the correlation between NLRP3 activation and endothelial-to-mesenchymal transition in the heart of a murine model of systemic sclerosis","volume":"14","author":"Irrera","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.berh.2026.102124_bib18","article-title":"Spatial proteomic-based phenotyping of fibroblast populations and their microenvironment in systemic sclerosis primary heart involvement","volume":"77","author":"Stuetz","year":"2025","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102124_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/ehjci\/jeac094","article-title":"Diffuse myocardial fibrosis precedes subclinical functional myocardial impairment and provides prognostic information in systemic sclerosis","volume":"24","author":"Gotschy","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.berh.2026.102124_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152137","article-title":"Disease specific determinants of cardiopulmonary fitness in systemic sclerosis","volume":"58","author":"Ross","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2026.102124_bib21","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/rheumatology\/key430","article-title":"Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP","volume":"58","author":"Bissell","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2026.102124_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/23971983251321691","article-title":"International expert agreement on World scleroderma foundation\/heart failure Association consensus-based definition and guidance on screening, diagnosis, and follow-up assessment of systemic sclerosis-associated primary heart involvement","author":"Dubas","year":"2025","journal-title":"J Scleroderma Relat Disord"},{"issue":"9","key":"10.1016\/j.berh.2026.102124_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/acr2.70030","article-title":"Limited utility of screening electrocardiograms in systemic sclerosis: data from the Canadian scleroderma research group","volume":"7","author":"Wojcik","year":"2025","journal-title":"ACR open rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2026.102124_bib24","article-title":"Association of systemic sclerosis with premature ventricular complexes and cardiac arrest: a national inpatient sample analysis for 2021","volume":"17","author":"Nwogwugwu","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.berh.2026.102124_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152229","article-title":"Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: a systematic review and meta-analysis","volume":"62","author":"Fairley","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"18","key":"10.1016\/j.berh.2026.102124_bib26","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/eurjpc\/zwae118","article-title":"Long-term rate of ventricular arrhythmia in autoimmune disease","volume":"31","author":"Sun","year":"2024","journal-title":"European journal of preventive cardiology"},{"issue":"3","key":"10.1016\/j.berh.2026.102124_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/23971983231163413","article-title":"Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World scleroderma foundation\/heart failure Association guidance on screening, diagnosis, and follow-up assessment","volume":"8","author":"Bruni","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"issue":"8","key":"10.1016\/j.berh.2026.102124_bib28","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/rheumatology\/kez494","article-title":"Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the scleroderma arrhythmia clinical utility study (SAnCtUS)","volume":"59","author":"Mavrogeni","year":"2020","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.berh.2026.102124_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.medcli.2022.11.022","article-title":"Left ventricular dysfunction and arrhythmias in asymptomatic patients with systemic sclerosis","volume":"160","author":"Lopez Nunez","year":"2023","journal-title":"Med Clin"},{"issue":"15","key":"10.1016\/j.berh.2026.102124_bib30","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1177\/2047487318786315","article-title":"Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis","volume":"25","author":"Guerra","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"10.1016\/j.berh.2026.102124_bib31","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.echo.2008.08.004","article-title":"Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using doppler measures of myocardial strain","volume":"21","author":"Mele","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.berh.2026.102124_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152443","article-title":"Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis","volume":"66","author":"Fairley","year":"2024","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2026.102124_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeae023","article-title":"Speckle-tracking global longitudinal strain predicts death and cardiovascular events in patients with systemic sclerosis","volume":"4","author":"Stronati","year":"2024","journal-title":"Eur Heart J Open"},{"issue":"1","key":"10.1016\/j.berh.2026.102124_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.semarthrit.2020.10.016","article-title":"Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review","volume":"51","author":"Ross","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2026.102124_bib35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/23971983241249209","article-title":"N-terminal pro-brain natriuretic peptide is associated with pulmonary hypertension or diastolic dysfunction in patients with systemic sclerosis: an Australian prospective cross-sectional study","volume":"9","author":"Ha","year":"2024","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.berh.2026.102124_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejim.2018.10.013","article-title":"Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: a prospective study","volume":"60","author":"Bosello","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"11","key":"10.1016\/j.berh.2026.102124_bib37","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1093\/rheumatology\/keac065","article-title":"Myocardial fibrosis and arrhythmic burden in systemic sclerosis","volume":"61","author":"Ross","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2026.102124_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejim.2020.05.042","article-title":"Screening for pulmonary arterial hypertension in systemic sclerosis: a systematic literature review","volume":"78","author":"Bruni","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"9","key":"10.1016\/j.berh.2026.102124_bib39","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1093\/rheumatology\/keaf234","article-title":"The complex diagnosis of primary heart involvement in systemic sclerosis: red flags to drive the choice of cardiac magnetic resonance","volume":"64","author":"Batani","year":"2025","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2026.102124_bib40","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1093\/rheumatology\/keaa742","article-title":"Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis","volume":"60","author":"Dumitru","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2026.102124_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13010089","article-title":"Digital ulcers and ventricular arrhythmias as red flags to predict replacement myocardial fibrosis in systemic sclerosis","volume":"13","author":"Gargani","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.berh.2026.102124_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003391","article-title":"Diffusing capacity of lungs for carbon monoxide associated with subclinical myocardial impairment in systemic sclerosis: a cardiac MR study","volume":"9","author":"He","year":"2023","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.berh.2026.102124_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036730","article-title":"Evaluation of systemic sclerosis primary heart involvement and chronic heart failure in the european scleroderma trials and research cohort","volume":"14","author":"Gyorfi","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.berh.2026.102124_bib44","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/rheumatology\/kead599","article-title":"Heart and systemic sclerosis-findings from a national cohort study","volume":"63","author":"Guedon","year":"2024","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.berh.2026.102124_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70094","article-title":"First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: clinical associations from the SPRING-SIR registry","volume":"55","author":"Tonutti","year":"2025","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.berh.2026.102124_bib46","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.semarthrit.2018.07.008","article-title":"Defining primary systemic sclerosis heart involvement: a scoping literature review","volume":"48","author":"Ross","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2026.102124_bib47","first-page":"882","article-title":"Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK systemic sclerosis study group cardiac working group","volume":"56","author":"Bissell","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2026.102124_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keag109","article-title":"Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement","author":"Ross","year":"2026","journal-title":"Rheumatology (Oxford)"},{"issue":"10513","key":"10.1016\/j.berh.2026.102124_bib49","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(25)01637-X","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2026.102124_bib50","article-title":"Increased incidence of sudden cardiac death in systemic sclerosis: estimate & correlates","volume":"77","author":"Fairley","year":"2025","journal-title":"Arthritis Rheumatol"},{"issue":"10354","key":"10.1016\/j.berh.2026.102124_bib51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2026.102124_bib52","article-title":"Cardiovascular and venous thromboembolic events in systemic sclerosis: epidemiological analysis of the clinical practice research datalink","author":"Pauling","year":"2025","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2026.102124_bib53","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1038\/s41598-024-57275-9","article-title":"Association between systemic sclerosis and risk of cerebrovascular and cardiovascular disease: a meta-analysis","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2026.102124_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152739","article-title":"Pathological contributors to organ damage and mortality in systemic sclerosis: a nationwide matched case-control study","volume":"73","author":"Fairley","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2026.102124_bib55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"Myocardial lesions of progressive systemic sclerosis A cause of cardiac dysfunction","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.berh.2026.102124_bib56","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10067-006-0211-8","article-title":"Acute myocardial infarction in systemic sclerosis patients: a case series","volume":"26","author":"Derk","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2026.102124_bib57","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X251357188","article-title":"Cardio-rheumatology: integrated care and the opportunities for personalized medicine","volume":"17","author":"Ruiz Maya","year":"2025","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"10.1016\/j.berh.2026.102124_bib58","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/jamacardio.2024.5644","article-title":"Coronary artery calcium testing-too early, too late, too often","volume":"10","author":"Zheutlin","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"7","key":"10.1016\/j.berh.2026.102124_bib59","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jcmg.2019.01.014","article-title":"The association of coronary artery calcification with subsuquent incidence of cardiovascular disease in type I diabetes: the DCCT\/EDIC trials","volume":"12","author":"Budoff","year":"2019","journal-title":"JACC, Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.berh.2026.102124_bib60","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/art.30283","article-title":"Systemic sclerosis is an independent risk factor for increased coronary artery calcium deposition","volume":"63","author":"Mok","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2026.102124_bib61","article-title":"Predictive modeling of cardiovascular risk in systemic sclerosis: a single-center retrospective study integrating clinical and imaging data","author":"Huang","year":"2025","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2026.102124_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152723","article-title":"Subclinical coronary artery calcification in systemic sclerosis using high-resolution chest CT: identification, extent, and disease-specific risk factors","volume":"73","author":"Naeser","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2026.102124_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152598","article-title":"Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: association with systemic sclerosis clinical features","volume":"70","author":"Luo","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.berh.2026.102124_bib64","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1093\/rheumatology\/keac072","article-title":"Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis","volume":"61","author":"Sun","year":"2022","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2026.102124_bib65","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ejhf.3541","article-title":"Long-term rate of heart failure in patients with autoimmune disease: a nationwide cohort study","volume":"27","author":"Sun","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.berh.2026.102124_bib66","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1093\/rheumatology\/keaf422","article-title":"Risk of ischaemic and non-ischaemic heart failure in patients wtih systemic sclerosis: a population-based study","volume":"64","author":"Bairkdar","year":"2025","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.berh.2026.102124_bib67","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/acr.25016","article-title":"Association of systemic sclerosis with incident clinically evident heart failure","volume":"75","author":"Lin","year":"2023","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.berh.2026.102124_bib68","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/ehf2.14457","article-title":"Systemic sclerosis is associated with increased in-patient mortality in patients hospitalized for heart failure","volume":"11","author":"Sherif","year":"2024","journal-title":"ESC Heart Fail"},{"issue":"10","key":"10.1016\/j.berh.2026.102124_bib69","first-page":"1986","article-title":"The clinical implications of left ventricular diastolic dysfunction in systemic sclerosis","volume":"40","author":"Ross","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"15","key":"10.1016\/j.berh.2026.102124_bib70","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2018.07.068","article-title":"Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis","volume":"72","author":"Tennoe","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.berh.2026.102124_bib71","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.amjmed.2025.08.009","article-title":"Sodium glucose Co-Transporter-2 inhibitors in patients with systemic sclerosis with or without heart failure","volume":"139","author":"Nunes Augusto","year":"2026","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.berh.2026.102124_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14124054","article-title":"The effectiveness of sacubitril\/valsartan in systemic sclerosis patients with heart failure: a retrospective analysis","volume":"14","author":"Eshak","year":"2025","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.berh.2026.102124_bib73","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2026.102124_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152622","article-title":"Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: an Italian cardiac magnetic resonance based study","volume":"71","author":"De Luca","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2026.102124_bib75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13023-023-02699-1","article-title":"The clinical characteristics and outcomes of patients with systemic sclerosis with myocardial involvement","volume":"18","author":"He","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.1016\/j.berh.2026.102124_bib76","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1093\/rheumatology\/keac674","article-title":"Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study","volume":"62","author":"Ninagawa","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2026.102124_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8884442","article-title":"Clinical outcomes of myocarditis after moderate-dose steroid therapy in systemic sclerosis: a pilot study","volume":"2020","author":"Pussadhamma","year":"2020","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.berh.2026.102124_bib78","article-title":"Cardiac magnetic resonance imaging before and after therapeutic interventions for systemic sclerosis-associated myocarditis","author":"Panopoulos","year":"2022","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2026.102124_bib79","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ejhf.3467","article-title":"Add-on rituximab for primary heart involvement associated with systemic sclerosis: a step forward in the tailored treatment of myocarditis?","volume":"27","author":"De Santis","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.berh.2026.102124_bib80","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/rir-2024-0015","article-title":"Outcomes of myocarditis in systemic sclerosis: a 3-year follow-up","volume":"5","author":"Mahakkanukrauh","year":"2024","journal-title":"Rheumatol Immunol Res"},{"issue":"2","key":"10.1016\/j.berh.2026.102124_bib81","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-005493","article-title":"Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 cases","volume":"11","author":"Adjailia","year":"2025","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.berh.2026.102124_bib82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00296-025-05874-8","article-title":"Cardiogenic shock in systemic sclerosis: a retrospective study of acute ventricular dysfunction","volume":"45","author":"Uribarri","year":"2025","journal-title":"Rheumatol Int"},{"issue":"10","key":"10.1016\/j.berh.2026.102124_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103162","article-title":"Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis","volume":"21","author":"Vigneron","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.berh.2026.102124_bib84","first-page":"2006","article-title":"Tocilizumab for systemic sclerosis cardiac involvement: a case report","volume":"40","author":"Lee","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2026.102124_bib85","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-Cell therapy in autoimmune disease - a case series with Follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.berh.2026.102124_bib86","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1093\/rheumatology\/keaa865","article-title":"Treatment of myocardial fibrosis in systemic sclerosis with tocilizumab","volume":"60","author":"Ishizaki","year":"2021","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2026.102124_bib87","article-title":"Acute systemic sclerosis-associated cardiomyopathy that improved with glucocorticoids and cyclophosphamide","volume":"30","author":"Gustafson","year":"2025","journal-title":"JACC Case Rep"},{"issue":"11","key":"10.1016\/j.berh.2026.102124_bib88","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2026.102124_bib89","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10067-013-2358-4","article-title":"Impact of cardiac involvement on the risk of mortality among patients with systemic sclerosis: a 5-year follow-up of a single-center cohort","volume":"33","author":"K\u00f6lt\u0151","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"SI","key":"10.1016\/j.berh.2026.102124_bib90","doi-asserted-by":"crossref","first-page":"SI20","DOI":"10.1093\/rheumatology\/keac256","article-title":"Evaluation of left cardiac chamber function with cardiac magnetic resonance and association with outcome in patients with systemic sclerosis","volume":"62","author":"Butcher","year":"2023","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2026.102124_bib91","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0002-9343(88)90305-1","article-title":"Prognostic importance of cardiac arrhythmias in systemic sclerosis","volume":"84","author":"Kostis","year":"1988","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.berh.2026.102124_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153012","article-title":"Prognostic role of ventricular ectopic beats in systemic sclerosis: a prospective cohort Study shows ECG indexes predicting the worse outcome","volume":"11","author":"De Luca","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.berh.2026.102124_bib93","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/eurheartj\/ehaa587","article-title":"Assessing left ventricular systolic function: from ejection fraction to strain analysis","volume":"42","author":"Halliday","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:47:12Z","timestamp":1781509632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694226000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1521694226000094"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2026.102124","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in the heart and soul of primary cardiac involvement and cardiovascular disease in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2026.102124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102124"}}